CMR Repeatability in STEMI

Cardiovascular Magnetic Resonance Scan Repeatability in ST Segment Elevation Myocardial Infarction

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01468662

Enrollment

Registered

2011-11-09

Start date

2011-11-30

Completion date

Unknown

Last updated

2014-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STEMI

Brief summary

The investigators propose to conduct a study to measure the reproducibility of CMR parameters that have been used to predict outcome following PPCI: infarct size, left ventricular volumes, myocardial salvage, microvascular obstruction (MVO) and myocardial oedema.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

Participant may enter study if ALL of the following apply 1. ST segment myocardial infarction as defined by ECG (by 2 contiguous limb leads with \>1 mm ST-segment elevation, or \>2 mm ST-segment elevation in contiguous precordial leads, or new LBBB) and \> 20 minutes of cardiac chest pain 2. Written informed consent

Exclusion criteria

Participant may not enter study if ANY of the following apply 1. Contraindication to MRI (implanted pacemaker/ defibrillator, ferromagnetic metal implant/ injury, claustrophobia, obesity/ too large for CMR scanner) 2. Known allergy to gadolinium 3. Chronic atrial fibrillation 4. Renal impairment with eGFR \<30 5. Cardiogenic shock 6. Patients with special communication needs

Design outcomes

Primary

Measure	Time frame
Inter-observer, intra-observer and inter-scan variability and agreement	Between 2 scans

Countries

United Kingdom

Outcome results